المؤلفون: Dhoot DS; California Retina Consultants/Retina Consultants of America, Santa Barbara, CA, USA., Moini H; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Reed K; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Du W; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Vitti R; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Berliner AJ; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Singh RP; Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA. drrishisingh@gmail.com.

المصدر: Eye (London, England) [Eye (Lond)] 2023 Jul; Vol. 37 (10), pp. 2020-2025. Date of Electronic Publication: 2022 Apr 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8703986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5454 (Electronic) Linking ISSN: 0950222X NLM ISO Abbreviation: Eye (Lond) Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus* , Diabetic Retinopathy*/diagnosis , Diabetic Retinopathy*/drug therapy , Diabetic Retinopathy*/surgery , Macular Edema*/diagnosis , Macular Edema*/drug therapy , Macular Edema*/surgery, Humans ; Angiogenesis Inhibitors/therapeutic use ; Intravitreal Injections ; Laser Coagulation/adverse effects ; Receptors, Vascular Endothelial Growth Factor/therapeutic use ; Recombinant Fusion Proteins/therapeutic use ; Tomography, Optical Coherence ; Treatment Outcome ; Vascular Endothelial Growth Factor A/therapeutic use ; Clinical Trials as Topic